Erika Mayer, MD, MPH, Dana-Farber Cancer Institute, discusses the exciting findings of the phase 3 lidERA study investigating ...

Meanwhile, people with overweight or obesity lost up to 11.3% more weight than placebo by week 36 with a novel GLP-1 agonist ...

Giredestrant, a selective estrogen receptor antagonist and degrader given as an adjuvant therapy, shows significant ...

New findings suggest that for people with prediabetes, normalizing blood sugar levels can help prevent heart disease. Learn ...

Continuous glucose monitoring may have a role in identifying and preventing diabetes among healthy adults, but more studies ...

Thyroid disorders, common endocrine conditions, often require long-term management. Shivkumar Aggarwal, seeking lasting ...

People who brought their blood glucose down to a normal level had a lower risk of death from heart disease or hospitalization ...

At the San Antonio Breast Cancer Symposium, researchers reported that real-time monitoring with smart pill bottles ...

People who had achieved remission from prediabetes had a 58% lower risk of cardiovascular death or hospitalisation from heart ...

Second-generation automated insulin delivery (AID) systems improve glycemic control and treatment satisfaction in type 1 diabetes.

The phase 3 MajesTEC-3 trial demonstrated that the combination of the bispecific BCMA-directed T-cell engager teclistamab and ...

Prediabetic patients, who lower their blood sugar levels and can achieve remission, can reduce the likelihood of serious ...